Clarity Sensors: £1.9 million NIHR award to develop second-generation photon-counting CT detectors with STFC
19 Nov 2026
PICASO builds on Clarity Sensors' European Innovation Council Transition grant, giving them £4 million of non-dilutive funding across two complementary programmes to take their perovskite detector technology towards clinical CT.
Clarity Sensors have been awarded a £1.9 million Product Development Award by the National Institute for Health and Care Research (NIHR), through its Invention for Innovation (i4i) programme, to lead PICASO. Beginning on the 1st October 2026, this is a three-year project with the Science and Technology Facilities Council (STFC) Detector Development Group.
PICASO joins PERFORM, the company’s €2.5 million (£2.1 million) Transition grant from the European Innovation Council (EIC), which they announced in April 2025. Together, the two awards provide £4 million of non-dilutive funding to Clarity Sensors, both won through competitive processes.
Why photon-counting CT matters
Photon-counting CT detects and measures each individual X-ray photon. In clinical use, it has been shown to produce sharper images at substantially lower radiation dose than conventional CT. For patients, lower dose matters most where exposure adds up: children, and people who need repeated scans to monitor cancer or heart disease. Sharper images can also support earlier, more confident diagnosis.
Yet most patients cannot benefit today. Photon-counting systems are premium priced and currently available only in specialist centres such as teaching hospitals. A key reason is the sensor material at their heart. Cadmium telluride and cadmium zinc telluride crystals take months to grow at high temperature, and only a small number of suppliers worldwide can make them at medical grade.
Their approach
Clarity Sensors are developing a second generation of photon-counting sensor based on halide perovskite single crystal semiconductors, which are grown in a matter of days at low temperature. The initial laboratory results show the sensors can already perform comparably with the cadmium telluride sensors used in current commercial systems on key detector measures, with further optimisation improvements to come.
Their aim is to make photon-counting detectors practical to manufacture at scale. That would allow the benefits of photon-counting CT to reach district general hospitals and community diagnostic centres, not only specialist centres.
What PICASO will deliver
PICASO pairs Clarity Sensors’ perovskite semiconductor sensors with readout electronics developed from the HEXITEC-MHz, the latest generation of STFC’s UK-designed X-ray imaging technology. Working with STFC’s Detector Development Group, they will adapt the HEXITEC-MHz readout chip for perovskite sensors. They will then build and validate a complete photon-counting detector module in a CT-relevant preclinical environment.
Over the three years, the aim is to:
- establish pilot-scale sensor production at their Cambridge facility;
- build their quality management system to meet ISO 9001 and the ISO 13485 requirements that apply to a supplier of a critical component in a CT scanner; and
- advance the technology from Technology Readiness Level 3 to 6, a level of maturity at which they can work with CT manufacturers on integration into their systems.
For CT manufacturers, a validated module and a route to quality-controlled production are what turn a promising material into a component they can design in. PICASO is built to deliver both.
Clarity Sensors’ PERFORM project, funded by the European Innovation Council, focuses on developing and validating the detector technology itself. PICASO builds on this with the work needed to move towards NHS use: testing complete detector modules under CT conditions, establishing a medical-device quality system, assessing the value to NHS services and involving patients and the public in shaping how the technology develops.
Grounded in clinical need
Two strands of PICASO keep the work focused on patients and the NHS.
First, they will work with an independent health economics consultancy to model the value of second-generation photon-counting CT to the NHS. The analysis will use national NHS data and focus on priority pathways, including coronary artery disease and the earlier diagnosis of cancer. This evidence will inform their discussions with CT manufacturers and NHS stakeholders about adoption.
Second, patients and members of the public will help shape the project through an advisory group and two structured workshops, run in conjunction with the NIHR Cambridge Biomedical Research Centre. The workshops will explore attitudes to CT imaging, radiation dose and screening, and the outcomes that matter most to the people who will one day benefit from the technology. Clarity Sensors will feed what they learn into the project’s design decisions, use the finding to shape the health economics study, and share a summary of the findings publicly after each workshop.
In their words
“Photon-counting CT offers real benefits for patients, but the materials it depends on today are slow and costly to make. We grow our perovskite sensors in a matter of days at low temperature, and our initial laboratory results show they can already perform comparably with the materials in current systems. This NIHR award, and our collaboration with STFC’s detector specialists, will allow us to turn these results into a complete detector module and test it under the conditions a CT scanner demands. It is a significant step towards our goal of supplying perovskite semiconductor detector technology to CT manufacturers.”
Dr Hayden Salway, CEO of Clarity Sensors, said.
“For 20 years, our HEXITEC® technology has advanced the field of colour X-ray imaging, bringing capabilities once confined to national science facilities into laboratories and industry. The combination of our next-generation HEXITEC-MHz detector technology with Clarity Sensors’ innovative perovskite semiconductor materials represents an exciting opportunity to widen access to affordable colour CT imaging. With NIHR funding, working with Clarity Sensors, we aim to advance knowledge of these emerging materials, improve lives through the development of more accessible medical imaging technologies, and drive growth by strengthening UK sovereign capability in advanced X-ray detector technologies.”
Dr Matthew Veale, Group Leader of the STFC Detector Development Group, said.
What comes next
PICASO runs until September 2029.
Acknowledgements
PICASO is funded by the National Institute for Health and Care Research (NIHR) Invention for Innovation (i4i) programme (NIHR514357). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Patient and public involvement in PICASO is supported by the NIHR Cambridge Biomedical Research Centre (NIHR203312). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
PERFORM is funded by the European Union through the European Innovation Council. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
HEXITEC® is a registered trademark of the Science and Technology Facilities Council.
This press release was originally shared by Clarity Sensors.